A modest dose of glycine, an inexpensive and simple amino acid, cuts the post-meal blood sugar excursion by more than half when consumed alongside carbohydrates. In a clinical crossover trial conducted at the Minneapolis Veterans Affairs Medical Center, researchers administered approximately five grams of oral glycine with 25 grams of glucose to healthy adults. The co-ingestion blunted the peak blood glucose spike by 15 percent and reduced the cumulative two-hour blood glucose exposure by over 50 percent compared to glucose alone. Surprisingly, this clearance occurred without requiring the pancreas to produce additional insulin. The findings suggest that glycine acts through an unidentified gut-derived signaling cascade that accelerates tissue glucose disposal, pointing to a straightforward dietary tactic for stabilizing postprandial glucose dynamics.
When dietary protein enters the digestive system alongside carbohydrates, it triggers an unexpected metabolic dampening effect. Decades of nutritional research established that whole proteins suppress the sharp blood sugar surges that normally follow carbohydrate consumption. Gelatin consistently emerged as one of the most potent suppressors in experimental settings. Because gelatin consists of roughly 30 percent glycine, investigators at the University of Minnesota set out to isolate the compound and test whether glycine alone drove this metabolic dampening.
The team designed a randomized, controlled crossover study evaluating nine healthy volunteers across four separate mornings. On different test days, participants drank plain water, 25 grams of glucose dissolved in water, an individualized dose of glycine adjusted to lean body mass (averaging 4.6 grams), or the combination of glycine and glucose. Blood samples taken every ten minutes for two hours mapped the minute-by-minute fluctuations of glucose, insulin, glucagon, and circulating amino acids.
The results challenged conventional endocrine assumptions. When volunteers consumed glucose alone, their blood sugar spiked quickly, reaching a peak at 30 minutes before returning to fasting levels at 70 minutes. When they consumed glycine alone, blood sugar barely shifted, but glucagon levels spiked dramatically and remained elevated for the entire two hours.
The critical insight emerged from the combined challenge. When participants drank the glycine and glucose mixture, peak blood glucose dropped by roughly 15 percent, and the total blood sugar exposure over two hours plunged by more than half. Most remarkably, this accelerated sugar clearance occurred without an increase in total insulin output. The cumulative insulin secretion curve for glycine plus glucose matched the curve for glucose alone almost exactly, though its peak was slightly delayed and broader.
Under normal physiological conditions, clearing a given load of sugar twice as fast requires either a surge in insulin or an intact delay in stomach emptying. Yet intravenous glycine infusions in earlier human trials failed to elicit either an insulin response or a drop in blood sugar. Because glycine acts only when swallowed, the authors deduced that its primary mechanism resides in the digestive tract. Glycine appears to trigger the release of a local gut hormone, an incretin-like messenger, that primes peripheral tissues to pull glucose out of circulation with extreme efficiency.
This discovery provides a mechanistic foundation for why whole food protein sources stabilize glycemic volatility. It also challenges the dogma that non-essential amino acids are metabolically inert bystanders. By demonstrating that a single, widely available amino acid can halve postprandial glycemic excursions in humans, the study opens a practical avenue for managing glucose without driving up pancreatic insulin demand.
Actionable Insights
Consuming three to five grams of pure glycine powder with a carbohydrate-dense meal substantially reduces post-meal glycemic exposure. In quantitative terms, the real-world effect size observed in this clinical trial is substantial: co-ingesting roughly five grams of glycine with 25 grams of rapid-acting carbohydrates produced a 53 percent reduction in total two-hour blood glucose area under the curve, alongside a 15 percent suppression of the peak glucose spike.
For longevity and metabolic health, mitigating postprandial glucose excursions reduces the formation of advanced glycation end-products, diminishes oxidative endothelial stress, and limits glycemic variability. Because the clearance occurs without forcing the pancreas to hypersecrete insulin, glycine improves functional glucose tolerance without promoting hyperinsulinemia.
Practical application involves dissolving three to five grams of pharmaceutical-grade glycine, which possesses a naturally sweet taste, into water or incorporating it directly into high-carbohydrate meals. Individuals utilizing continuous glucose monitors can expect lower peak amplitudes and a faster return to baseline. However, because glycine stimulates significant glucagon secretion when consumed in isolation, its glycemic-blunting utility applies specifically to co-ingestion with carbohydrates rather than as a standalone fasting supplement.
Context and Source
- Open Access Paper: The metabolic response to ingested glycine
- Institution: Metabolic Research Laboratory and the Section of Endocrinology, Metabolism, and Nutrition, Minneapolis VA Medical Center, and the Departments of Medicine and Food Science and Nutrition, University of Minnesota
- Country: United States
- Journal Name: The American Journal of Clinical Nutrition (Volume 76, Issue 6, Pages 1302 to 1307)
- Impact Evaluation: The impact score of this journal is 7.1, evaluated against a typical high-end range of 0 to 60+ for top general science, therefore this is a High impact journal.
